London & Capital Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-12,883
| Closed | -$1.74M | – | 69 |
|
|
2021
Q4 | $1.74M | Sell |
12,883
-35
| -0.3% | -$4.74K | 0.11% | 55 |
|
|
2021
Q3 | $1.39M | Buy |
+12,918
| New | +$1.39M | 0.1% | 57 |
|
|
2021
Q2 | – | Sell |
-11,979
| Closed | -$1.3M | – | 82 |
|
|
2021
Q1 | $1.3M | Buy |
11,979
+1,391
| +13% | +$150K | 0.12% | 60 |
|
|
2020
Q4 | $1.14M | Buy |
+10,588
| New | +$1.14M | 0.13% | 56 |
|
|
2020
Q3 | – | Sell |
-6,596
| Closed | -$648K | – | 61 |
|
|
2020
Q2 | $648K | Buy |
6,596
+1,000
| +18% | +$98.2K | 0.11% | 55 |
|
|
2020
Q1 | $426K | Hold |
5,596
| – | – | 0.1% | 56 |
|
|
2019
Q4 | $495K | Buy |
5,596
+36
| +0.6% | +$3.18K | 0.08% | 69 |
|
|
2019
Q3 | $421K | Sell |
5,560
-2,412
| -30% | -$183K | 0.07% | 67 |
|
|
2019
Q2 | $580K | Buy |
7,972
+5,079
| +176% | +$370K | 0.12% | 64 |
|
|
2019
Q1 | $233K | Buy |
2,893
+246
| +9% | +$19.8K | 0.04% | 80 |
|
|
2018
Q4 | $244K | Buy |
+2,647
| New | +$244K | 0.04% | 77 |
|